U.S. Clinical Trials Market Size Is Expected To Reach .3 Billion by 2030Posted by Sona Kulkarni on August 29th, 2023 U.S. Clinical Trials Market Growth & TrendsThe U.S. clinical trials market size is expected to reach USD 36.3 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.4% from 2022 to 2030. The increasing prevalence of chronic disease and growing demand for clinical trials in the U.S. is boosting the growth of the market. The number of people diagnosed with cancer is expected to increase multi-fold in the coming eight years. Although survivors have increased considerably owing to research in the oncology field, the number of cancer patients is expected to increase across the world. Pancreatic cancer has a poor prognosis with a survival of only 1 to 3 years. Approximately 13 people are diagnosed with GI stromal tumors each day. More than 60, 000 new cases of renal cell carcinoma are diagnosed every year in the U.S. Hence, representing an increasing prevalence of cancer and the need for effective treatments against various types of cancer. Investment in R&D is expected to grow owing to the disease prevalence across the U.S. thereby boosting the industry’s growth. The COVID-19 pandemic has halted new research projects and reallocated resources for other diseases. The supply chain for clinical trial samples has also been interrupted as a result of blocked borders. Hence, this market is disrupted. However, the COVID-19 response has resulted in new developments on the market that have transformed the conduct of clinical trials. Decentralized/virtual clinical trials are one such technique. Virtual trials have a very important role in the current COVID-19 scenario. As a result of the virtual visit and remote patient monitoring, participants have a choice and peace of mind to minimize risks. Monitoring gadgets, software tools, and mobile phones enable participants to complete the experiment from their homes. Request a free sample copy or view the report summary: U.S. Clinical Trials Market Report U.S. Clinical Trials Market Report Highlights
Access Press Release@ https://www.grandviewresearch.com/press-release/us-clinical-trials-market-analysis U.S. Clinical Trials Market Segmentation Grand View Research has segmented the U.S. Clinical Trials Market based on phase, study design, and indication: U.S. Clinical Trials Phase Outlook (Revenue, USD Million, 2018 - 2030)
U.S. Clinical Trials Study Design Outlook (Revenue, USD Million, 2018 - 2030)
U.S. Clinical Trials Indication Outlook (Revenue, USD Million, 2018 - 2030)
List of Key Players in the U.S. Clinical Trials Market
About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Like it? Share it!More by this author
|